ABSTRACT
OBJECTIVE: To characterize the existence and role of transforming growth factor-beta (TGF-beta) in otitis media with effusion (OME). STUDY DESIGN: Retrospective. METHODS: The levels of two major TGF-beta isoforms, TGF-beta1 and TGF-beta2, in the middle ear effusions (MEEs) of 44 children were evaluated using enzyme-linked immunospecific assays (ELISAs). Forty-eight MEEs were separated into three clinically relevant groups (i.e., serous, mucoid, and purulent), and TGF-beta levels were correlated with clinical parameters of disease for these MEEs. RESULTS: Both TGF-beta1 and TGF-beta2 were present in the samples. Mean levels of TGF-beta1 (920.36 +/- 437.75 pg/mg total protein) were generally 100-fold greater than those of TGF-beta2 (9.65 +/- 11.19 pg/mg total protein). TGF-beta1 levels were elevated in association with a history of previous tympanostomy tube placements (TTPs) (P = .029) and mucoid effusions (P = .042). TGF-beta2 levels were elevated in association with a history of previous TTPs (P = .100) and chronic (i.e., serous or mucoid) effusions (P = .003). CONCLUSIONS: TGF-beta1 is present in the MEEs of children with OME. Furthermore, TGF-beta1 and TGF-beta2 levels were elevated differentially in the presence of chronic disease indicators in OME, suggesting that these isoforms may have differing roles in the inflammatory processes that characterize OME.
Subject(s)
Exudates and Transudates/chemistry , Otitis Media with Effusion/immunology , Otitis Media, Suppurative/immunology , Transforming Growth Factor beta/analysis , Child , Child, Preschool , Chronic Disease , Enzyme-Linked Immunosorbent Assay , Female , Humans , Infant , Isomerism , Male , Middle Ear Ventilation , Otitis Media with Effusion/classification , Otitis Media with Effusion/surgery , Otitis Media, Suppurative/classification , Otitis Media, Suppurative/surgery , Recurrence , Risk Factors , Transforming Growth Factor alpha/analysis , Transforming Growth Factor beta/immunologySubject(s)
Endoscopy , Nose Neoplasms/surgery , Papilloma, Inverted/surgery , Child , Humans , Male , Nose Neoplasms/diagnosis , Papilloma, Inverted/diagnosisABSTRACT
Frequency-domain fluorescence lifetime techniques were used for the characterization of pooled human serum, including normal serum, hyperlipid serum, and sera that had been stripped of various components. Fluorescence lifetime measurements of normal human serum revealed lifetime components primarily in the regions of 10(2) ps, 1-2 ns, 4-7 ns, and 9-10 ns. Phase-resolved fluorescence spectroscopy (PRFS), a frequency-domain technique that combines spectral and lifetime information, in measurements of phase-resolved fluorescence intensity (PRFI), provided the basis for comparison of the various sera. Measurements of PRFI vs excitation wavelength and emission wavelength yield a phase-resolved excitation-emission matrix (PREEM) at a given modulation frequency. Multifrequency measurements yield a three-way excitation-emission-frequency array. The multifrequency PREEMs of the various sera were compared with each other and with the corresponding two-way excitation-emission matrices (EEMs) that are obtained using conventional, steady-state fluorescence spectroscopy. Application of matrix-based analysis techniques to the steady-state and PRFS data arrays allowed direct comparison between the two approaches. Results demonstrate the enhanced discrimination among samples that is achieved through the additional dimension of fluorescence lifetime in PRFS.
